Home > Insider Trading > Filing (0001209191-14-050025)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314596	Keith Katkin	20 Enterprise, Suite 200 Aliso Viejo CA 92656	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-08-01	9,670	$5.26	760,412	Yes	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Yes	4	S	Direct

Footnotes

1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. A majority of the proceeds from the sales will be used to pay required withholdings due by the Reporting Person. Following the sales reported on this Form 4, the Reporting Person as a total of 1,322,154 options to purchase shares of common stock that are vested and immediately exercisable and a total of 442,187 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 597,781 unvested Restricted Stock Units, of which 97,250 are performance-based Restricted Stock Units.
2. Represents the weighted-average price at which shares were sold within a range between $5.23 and $5.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
3. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.